Company Filing History:
Years Active: 2003-2012
Title: Mark Purdie: Innovator in Chemical Processes
Introduction
Mark Purdie is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of chemical processes, particularly in the pharmaceutical industry. With a total of 5 patents to his name, Purdie's work has had a considerable impact on drug development.
Latest Patents
Among his latest patents is a groundbreaking invention related to the compound 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline. This invention focuses on chemical processes useful in the manufacture of this compound, which is the active entity within AZD0530. It also covers intermediates useful in the manufacture of that compound and processes for their production. Additionally, Purdie's invention includes particular crystalline forms of the compound, such as a difumarate salt and a trihydrate, along with pharmaceutical compositions containing these crystalline forms. Another significant invention provides compounds that modulate chemokine activity, particularly CCR3, which can be used in treating asthma.
Career Highlights
Mark Purdie has worked with prominent companies in the pharmaceutical sector, including AstraZeneca AB and AstraZeneca UK Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in chemical processes.
Collaborations
Throughout his career, Purdie has collaborated with talented individuals such as Philip O'Keefe and Lilian Alcaraz. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Mark Purdie's contributions to the field of chemical processes and his innovative patents have made a significant impact on the pharmaceutical industry. His work continues to influence drug development and treatment options for various medical conditions.